These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 12838287
1. Life-threatening pulmonary hemorrhages post bone marrow transplantation in Hurler syndrome. Report of three cases and review of the literature. Gassas A, Sung L, Doyle JJ, Clarke JT, Saunders EF. Bone Marrow Transplant; 2003 Jul; 32(2):213-5. PubMed ID: 12838287 [Abstract] [Full Text] [Related]
2. The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I. Fleming DR, Henslee-Downey PJ, Ciocci G, Romond EH, Marciniak E, Munn RK, Thompson JS. Pediatr Transplant; 1998 Nov; 2(4):299-304. PubMed ID: 10084733 [Abstract] [Full Text] [Related]
3. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome. Tolar J, Grewal SS, Bjoraker KJ, Whitley CB, Shapiro EG, Charnas L, Orchard PJ. Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941 [Abstract] [Full Text] [Related]
4. Psychosocial outcomes of bone marrow transplant for individuals affected by Mucopolysaccharidosis I Hurler Disease: patient social competency. Pitt C, Lavery C, Wager N. Child Care Health Dev; 2009 Mar; 35(2):271-80. PubMed ID: 19228160 [Abstract] [Full Text] [Related]
5. Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler. Ferrara G, Maximova N, Zennaro F, Gregori M, Tamaro P. Pediatr Transplant; 2014 May; 18(3):E96-9. PubMed ID: 24483599 [Abstract] [Full Text] [Related]
6. Mixed donor chimerism and low level iduronidase expression may be adequate for neurodevelopmental protection in Hurler Syndrome. Conway J, Dyack S, Crooks BN, Fernandez CV. J Pediatr; 2005 Jul; 147(1):106-8. PubMed ID: 16027706 [Abstract] [Full Text] [Related]
7. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Peters C, Shapiro EG, Anderson J, Henslee-Downey PJ, Klemperer MR, Cowan MJ, Saunders EF, deAlarcon PA, Twist C, Nachman JB, Hale GA, Harris RE, Rozans MK, Kurtzberg J, Grayson GH, Williams TE, Lenarsky C, Wagner JE, Krivit W. Blood; 1998 Apr 01; 91(7):2601-8. PubMed ID: 9516162 [Abstract] [Full Text] [Related]
8. Hurler syndrome: a case report of a 5-year follow-up of dental findings after bone marrow transplantation. Wadenya RO, Stout AM, Gupta A, Monge J. Spec Care Dentist; 2010 Apr 01; 30(1):14-7. PubMed ID: 20051069 [Abstract] [Full Text] [Related]
9. [Allogeneic bone marrow transplantation in the treatment of (lysosomal) storage diseases]. Maaswinkel-Mooij PD, Poorthuis BJ, Hoogerbrugge PM, Brouwer OF, Vossen JM. Ned Tijdschr Geneeskd; 1998 Jan 24; 142(4):169-74. PubMed ID: 9557021 [Abstract] [Full Text] [Related]
10. Natural history of pulmonary complications in children after bone marrow transplantation. Eikenberry M, Bartakova H, Defor T, Haddad IY, Ramsay NK, Blazar BR, Milla CE, Cornfield DN. Biol Blood Marrow Transplant; 2005 Jan 24; 11(1):56-64. PubMed ID: 15625545 [Abstract] [Full Text] [Related]
11. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT). Malm G, Gustafsson B, Berglund G, Lindström M, Naess K, Borgström B, von Döbeln U, Ringdén O. Acta Paediatr; 2008 Aug 24; 97(8):1108-12. PubMed ID: 18452566 [Abstract] [Full Text] [Related]
12. Idiopathic hyperammonemia following an unrelated cord blood transplant for mucopolysaccharidosis I. Snyder MJ, Bradford WD, Kishnani PS, Hale LP. Pediatr Dev Pathol; 2003 Aug 24; 6(1):78-83. PubMed ID: 12481230 [Abstract] [Full Text] [Related]
13. [Diffuse alveolar hemorrhage after allogeneic bone marrow transplantation]. Ishida T, Arita M, Fujimori N. Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar 24; 34(3):369-73. PubMed ID: 8778482 [Abstract] [Full Text] [Related]
15. Mucopolysaccharidoses type I and IVA: clinical features and consanguinity in Tunisia. Khedhiri S, Chkioua L, Bouzidi H, Dandana A, Ben Turkia H, Miled A, Laradi S. Pathol Biol (Paris); 2009 Jul 24; 57(5):392-7. PubMed ID: 18584975 [Abstract] [Full Text] [Related]
16. Enzyme replacement therapy in mucopolysaccharidosis type I: progress and emerging difficulties. Wraith JE. J Inherit Metab Dis; 2001 Apr 24; 24(2):245-50. PubMed ID: 11405343 [Abstract] [Full Text] [Related]
17. Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I. Pievani A, Azario I, Antolini L, Shimada T, Patel P, Remoli C, Rambaldi B, Valsecchi MG, Riminucci M, Biondi A, Tomatsu S, Serafini M. Blood; 2015 Mar 05; 125(10):1662-71. PubMed ID: 25298037 [Abstract] [Full Text] [Related]
18. Towards gene therapy of Hurler syndrome. Fairbairn LJ, Lashford LS, Spooncer E, McDermott RH, Lebens G, Arrand JE, Arrand JR, Bellantuono I, Holt R, Hatton CE, Cooper A, Besley GT, Wraith JE, Anson DS, Hopwood JJ, Dexter TM. Cas Lek Cesk; 1997 Jan 08; 136(1):27-31. PubMed ID: 9127508 [Abstract] [Full Text] [Related]
19. Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management. Kirkpatrick K, Ellwood J, Walker RW. Paediatr Anaesth; 2012 Aug 08; 22(8):745-51. PubMed ID: 22672476 [Abstract] [Full Text] [Related]
20. Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation. Valayannopoulos V, de Blic J, Mahlaoui N, Stos B, Jaubert F, Bonnet D, Fischer A, de Lonlay P. Pediatrics; 2010 Nov 08; 126(5):e1242-7. PubMed ID: 20974778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]